NIH R01 · 2024
Advancing VR-based attentional bias as a biomarker for tobacco use disorder
PROJECT SUMMARY There are few effective treatment options for smoking cessation. The identification and validation of reliable biomarkers for tobacco use disorder has the potential to greatly facilitate treatment development and improve clinical outcomes. Attentional bias, a behavioral correlate and potential biomarker of addiction, is consistently observed in nicotine users and is related to the risk of subsequent relapse following smoking cessation. Our group has developed and tested a novel virtual reality (VR) nicotine cue exposure paradigm with promising preliminary results, including obtaining large nicotine-related attentional bias effect sizes. Thus, the goal of the proposed project…
From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.